Genetic Technologies Stock Price on April 9, 2021
| GENE Stock | USD 2.39 0.02 0.84% |
Below is the normalized historical share price chart for Genetic Technologies extending back to September 02, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Genetic Technologies stands at 2.39, as last reported on the 25th of April, with the highest price reaching 2.44 and the lowest price hitting 2.26 during the day.
If you're considering investing in Genetic Stock, it is important to understand the factors that can impact its price. Genetic Technologies appears to be dangerous, given 3 months investment horizon. Genetic Technologies holds Efficiency (Sharpe) Ratio of 0.0479, which attests that the entity had a 0.0479% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Genetic Technologies, which you can use to evaluate the volatility of the firm. Please utilize Genetic Technologies' Market Risk Adjusted Performance of (0.58), downside deviation of 5.18, and Risk Adjusted Performance of 0.0722 to validate if our risk estimates are consistent with your expectations.
At present, Genetic Technologies' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 14.4 M, whereas Other Stockholder Equity is forecasted to decline to about 7.1 M. . As of April 25, 2024, Price To Sales Ratio is expected to decline to 62.62. In addition to that, Price Earnings Ratio is expected to decline to -51.16. Genetic Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of September 2005 | 200 Day MA 3.1733 | 50 Day MA 2.553 | Beta 0.373 |
Genetic |
Sharpe Ratio = 0.0479
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GENE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.11 actual daily | 45 55% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Genetic Technologies is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genetic Technologies by adding it to a well-diversified portfolio.
Price Book 4.0804 | Enterprise Value Ebitda (0.91) | Price Sales 1.2896 | Shares Float 103.5 M | Wall Street Target Price 12.5 |
Genetic Technologies Valuation on April 9, 2021
It is possible to determine the worth of Genetic Technologies on a given historical date. On April 9, 2021 Genetic was worth 1.84 at the beginning of the trading date compared to the closed value of 9.05. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Genetic Technologies stock. Still, in general, we apply an absolute valuation method to find Genetic Technologies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Genetic Technologies where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Genetic Technologies' related companies.
| Open | High | Low | Close | Volume | |
04/11/2022 | 1.84 | 9.05 | 9.05 | 9.05 | 10,089 |
| 1.81 | 9.00 | 9.00 | 9.00 | 4,623 |
| Backtest Genetic Technologies | | | Genetic Technologies History | | | Genetic Technologies Valuation | Next |
Genetic Technologies Trading Date Momentum on April 9, 2021
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Genetic Technologies Fundamentals Correlations and Trends
By evaluating Genetic Technologies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Genetic Technologies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Genetic financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Genetic Technologies Stock history
Genetic Technologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Genetic is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Genetic Technologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Genetic Technologies stock prices may prove useful in developing a viable investing in Genetic Technologies
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 116.6 M | 122.4 M | |
| Net Loss | -10.6 M | -11.1 M |
Genetic Technologies Quarterly Net Working Capital |
|
Genetic Technologies Stock Technical Analysis
Genetic Technologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Genetic Technologies Period Price Range
Low | April 11, 2022
| High |
1.84 | 9.05 |
Genetic Technologies April 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Genetic Technologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genetic Technologies shares will generate the highest return on investment. By undertsting and applying Genetic Technologies stock market strength indicators, traders can identify Genetic Technologies entry and exit signals to maximize returns
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 4.92 | |||
| Day Median Price | 9.05 | |||
| Day Typical Price | 9.05 | |||
| Price Action Indicator | 3.61 | |||
| Period Momentum Indicator | (6.66) |
Genetic Technologies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Genetic Technologies' price direction in advance. Along with the technical and fundamental analysis of Genetic Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Genetic to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0722 | |||
| Jensen Alpha | 0.5647 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.0812 | |||
| Treynor Ratio | (0.59) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genetic Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Genetic Stock refer to our How to Trade Genetic Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Genetic Stock analysis
When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Genetic Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genetic Technologies. If investors know Genetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genetic Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 2.73 | Quarterly Revenue Growth (0.02) | Return On Assets (0.53) | Return On Equity (1.60) |
The market value of Genetic Technologies is measured differently than its book value, which is the value of Genetic that is recorded on the company's balance sheet. Investors also form their own opinion of Genetic Technologies' value that differs from its market value or its book value, called intrinsic value, which is Genetic Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genetic Technologies' market value can be influenced by many factors that don't directly affect Genetic Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genetic Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Genetic Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genetic Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.